AnaptysBio (ANAB)
(Real Time Quote from BATS)
$37.82 USD
+0.29 (0.77%)
Updated Sep 20, 2024 09:56 AM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -1.72 |
EPS Last Quarter | -1.71 |
Last EPS Surprise | -42.50% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -6.84 |
Next Year | -7.13 |
EPS (TTM) | -6.35 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.92M | 8.11M | 31.89M | 36.00M |
# of Estimates | 6 | 6 | 7 | 6 |
High Estimate | 11.30M | 11.64M | 41.09M | 53.09M |
Low Estimate | 3.00M | 3.00M | 18.15M | 12.00M |
Year ago Sales | 3.32M | 9.01M | 17.16M | 31.89M |
Year over Year Growth Est. | 138.43% | -10.03% | 85.88% | 12.88% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.72 | -1.74 | -6.84 | -7.13 |
# of Estimates | 8 | 7 | 8 | 8 |
Most Recent Consensus | -1.57 | -1.78 | -6.70 | -8.47 |
High Estimate | -1.57 | -1.55 | -6.48 | -6.03 |
Low Estimate | -1.99 | -2.01 | -7.36 | -8.47 |
Year ago EPS | -1.41 | -1.59 | -6.08 | -6.84 |
Year over Year Growth Est. | -21.99% | -9.43% | -12.50% | -4.28% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 4 | 6 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.72 | -1.74 | -6.84 | -7.13 |
7 Days Ago | -1.72 | -1.74 | -6.84 | -7.13 |
30 Days Ago | -1.72 | -1.74 | -6.84 | -7.13 |
60 Days Ago | -1.70 | -1.69 | -5.98 | -6.82 |
90 Days Ago | -1.69 | -1.65 | -5.92 | -6.49 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.72 | -1.74 | -6.84 | -7.13 |
Zacks Consensus Estimate | -1.72 | -1.74 | -6.84 | -7.13 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.71 | -1.64 | -1.59 | -1.41 | NA |
Estimate | -1.20 | -1.54 | -1.74 | -1.72 | NA |
Difference | -0.51 | -0.10 | 0.15 | 0.31 | -0.04 |
Surprise | -42.50% | -6.49% | 8.62% | 18.02% | -5.59% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more